Product Name

  • Name

    Cibenzoline succinate

  • EINECS 260-856-8
  • CAS No. 57625-97-5
  • Article Data2
  • CAS DataBase
  • Density g/cm3
  • Solubility
  • Melting Point
  • Formula C36H36N4•C4H6O4
  • Boiling Point 449.2 °C at 760 mmHg
  • Molecular Weight 380.444
  • Flash Point 225.5 °C
  • Transport Information
  • Appearance
  • Safety A poison by intravenous route. Human systemic effects: ocular ptosis, muscle weakness. When heated to decomposition it emits toxic vapors of NOx.
  • Risk Codes
  • Molecular Structure Molecular Structure of 57625-97-5 (Cibenzoline succinate)
  • Hazard Symbols
  • Synonyms CIBENZOLINE SUCCINATE;cifenlinesuccinate
  • PSA 123.38000
  • LogP 5.45320

2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) Chemical Properties

Molecular Structure of 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) (CAS NO.57625-97-5):

IUPAC Name: butanedioic acid; 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole
Empirical Formula: C40H42N4O
Molecular Weight: 642.7859 
Flash Point: 225.5 °C
Enthalpy of Vaporization: 68.06 kJ/mol 
Boiling Point: 449.2 °C at 760 mmHg
Vapour Pressure: 7.75E-08 mmHg at 25°C 
Synonyms of 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) (CAS NO.57625-97-5):
2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1H-imidazole succinate (2:1) ; Butanedioic acid, compd. with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:2) ; Succinic acid, compound with 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole (1:2)

2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 41500ug/kg (41.5mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
Kiso to Rinsho. Clinical Report. Vol. 22, Pg. 4485, 1988.
women TDLo oral 300mg/kg/22W- (300mg/kg) SENSE ORGANS AND SPECIAL SENSES: PTOSIS: EYE

BEHAVIORAL: MUSCLE WEAKNESS
Internal Medicine. Vol. 35, Pg. 512, 1996.


 

2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) Consensus Reports

 2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) (CAS NO.57625-97-5) was reported by KSRNAM Kiso to Rinsho in Clinical Report.

2-(2,2-Diphenylcyclopropyl)-4,5-dihydro-1h-imidazole succinate (2:1) Safety Profile

A poison by intravenous route. Human systemic effects: ocular ptosis, muscle weakness. When heated to decomposition it emits toxic vapors of NOx.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View